{"pmid":32396504,"title":"Abdominal Visceral Infarction in 3 Patients with COVID-19.","text":["Abdominal Visceral Infarction in 3 Patients with COVID-19.","A high incidence of thrombotic events has been reported in patients with coronavirus disease (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We report 3 clinical cases of patients in Italy with COVID-19 who developed abdominal viscera infarction, demonstrated by computed tomography.","Emerg Infect Dis","Besutti, Giulia","Bonacini, Riccardo","Iotti, Valentina","Marini, Giulia","Riva, Nicoletta","Dolci, Giovanni","Maiorana, Mariarosa","Spaggiari, Lucia","Monelli, Filippo","Ligabue, Guido","Guaraldi, Giovanni","Rossi, Paolo Giorgi","Pattacini, Pierpaolo","Massari, Marco","32396504"],"abstract":["A high incidence of thrombotic events has been reported in patients with coronavirus disease (COVID-19), which is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. We report 3 clinical cases of patients in Italy with COVID-19 who developed abdominal viscera infarction, demonstrated by computed tomography."],"journal":"Emerg Infect Dis","authors":["Besutti, Giulia","Bonacini, Riccardo","Iotti, Valentina","Marini, Giulia","Riva, Nicoletta","Dolci, Giovanni","Maiorana, Mariarosa","Spaggiari, Lucia","Monelli, Filippo","Ligabue, Guido","Guaraldi, Giovanni","Rossi, Paolo Giorgi","Pattacini, Pierpaolo","Massari, Marco"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32396504","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.3201/eid2608.201161","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","abdominal viscera","coronavirus","infarction","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["Italy"],"countries":["Italy"],"countries_codes":["ITA|Italy"],"topics":["Case Report"],"weight":1,"_version_":1666627827784482816,"score":9.490897,"similar":[{"pmid":32453685,"title":"Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.","text":["Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.","We describe 2 cases in coronavirus disease patients in France involving presumed thrombotic stroke that occurred during ongoing anticoagulation treatment for atrial fibrillation stroke prophylaxis; 1 patient had positive antiphospholipid antibodies. These cases highlight the severe and unique consequences of coronavirus disease-associated stroke.","Emerg Infect Dis","Zayet, Souheil","Klopfenstein, Timothee","Kovacs, Robert","Stancescu, Silviu","Hagenkotter, Beate","32453685"],"abstract":["We describe 2 cases in coronavirus disease patients in France involving presumed thrombotic stroke that occurred during ongoing anticoagulation treatment for atrial fibrillation stroke prophylaxis; 1 patient had positive antiphospholipid antibodies. These cases highlight the severe and unique consequences of coronavirus disease-associated stroke."],"journal":"Emerg Infect Dis","authors":["Zayet, Souheil","Klopfenstein, Timothee","Kovacs, Robert","Stancescu, Silviu","Hagenkotter, Beate"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32453685","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3201/eid2609.201791","keywords":["2019 novel coronavirus disease","covid-19","coronavirus diseases","france","sars-cov-2","central nervous system","infarction","pneumonia","respiratory diseases","severe acute respiratory syndrome coronavirus 2","stroke","viruses","zoonoses"],"locations":["France","France"],"countries":["France"],"countries_codes":["FRA|France"],"topics":["Case Report"],"weight":1,"_version_":1667983494557466626,"score":201.77821},{"pmid":32330112,"title":"Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China.","text":["Asymptomatic SARS-CoV-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China.","We found that all 5 asymptomatic household contacts of a Wuhan, China, physician with coronavirus disease had severe acute respiratory syndrome coronavirus 2 detected by PCR. The index patient and 2 contacts also had abnormal chest computed tomography scans. Asymptomatic infected household contacts of healthcare workers with coronavirus disease might be underrecognized.","Emerg Infect Dis","Luo, Yi","Trevathan, Edwin","Qian, Zhengmin","Li, Yirong","Li, Jin","Xiao, Wei","Tu, Ning","Zeng, Zhikun","Mo, Pingzheng","Xiong, Yong","Ye, Guangming","32330112"],"abstract":["We found that all 5 asymptomatic household contacts of a Wuhan, China, physician with coronavirus disease had severe acute respiratory syndrome coronavirus 2 detected by PCR. The index patient and 2 contacts also had abnormal chest computed tomography scans. Asymptomatic infected household contacts of healthcare workers with coronavirus disease might be underrecognized."],"journal":"Emerg Infect Dis","authors":["Luo, Yi","Trevathan, Edwin","Qian, Zhengmin","Li, Yirong","Li, Jin","Xiao, Wei","Tu, Ning","Zeng, Zhikun","Mo, Pingzheng","Xiong, Yong","Ye, Guangming"],"date":"2020-04-25T11:00:00Z","year":2020,"_id":"32330112","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.3201/eid2608.201016","keywords":["2019 novel coronavirus disease","covid-19","china","sars-cov-2","wuhan","asymptomatic","coronavirus disease","healthcare workers","household contacts","respiratory infections","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["Wuhan","China","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission"],"weight":1,"_version_":1666138494585536513,"score":140.82358},{"pmid":32187007,"title":"Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2.","text":["Identifying and Interrupting Superspreading Events-Implications for Control of Severe Acute Respiratory Syndrome Coronavirus 2.","It appears inevitable that severe acute respiratory syndrome coronavirus 2 will continue to spread. Although we still have limited information on the epidemiology of this virus, there have been multiple reports of superspreading events (SSEs), which are associated with both explosive growth early in an outbreak and sustained transmission in later stages. Although SSEs appear to be difficult to predict and therefore difficult to prevent, core public health actions can prevent and reduce the number and impact of SSEs. To prevent and control of SSEs, speed is essential. Prevention and mitigation of SSEs depends, first and foremost, on quickly recognizing and understanding these events, particularly within healthcare settings. Better understanding transmission dynamics associated with SSEs, identifying and mitigating high-risk settings, strict adherence to healthcare infection prevention and control measures, and timely implementation of nonpharmaceutical interventions can help prevent and control severe acute respiratory syndrome coronavirus 2, as well as future infectious disease outbreaks.","Emerg Infect Dis","Frieden, Thomas R","Lee, Christopher T","32187007"],"abstract":["It appears inevitable that severe acute respiratory syndrome coronavirus 2 will continue to spread. Although we still have limited information on the epidemiology of this virus, there have been multiple reports of superspreading events (SSEs), which are associated with both explosive growth early in an outbreak and sustained transmission in later stages. Although SSEs appear to be difficult to predict and therefore difficult to prevent, core public health actions can prevent and reduce the number and impact of SSEs. To prevent and control of SSEs, speed is essential. Prevention and mitigation of SSEs depends, first and foremost, on quickly recognizing and understanding these events, particularly within healthcare settings. Better understanding transmission dynamics associated with SSEs, identifying and mitigating high-risk settings, strict adherence to healthcare infection prevention and control measures, and timely implementation of nonpharmaceutical interventions can help prevent and control severe acute respiratory syndrome coronavirus 2, as well as future infectious disease outbreaks."],"journal":"Emerg Infect Dis","authors":["Frieden, Thomas R","Lee, Christopher T"],"date":"2020-03-19T11:00:00Z","year":2020,"_id":"32187007","source":"PubMed","week":"202012|Mar 16 - Mar 22","doi":"10.3201/eid2606.200495","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","sses","behavioral factors","coronavirus","disease control","environmental factors","host factors","outbreaks","pathogen-specific factors","respiratory infections","response factors","severe acute respiratory syndrome coronavirus 2","superspreading events","viruses","zoonoses"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1666138492522987523,"score":135.30223},{"pmid":32364890,"title":"Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic.","text":["Evidence Supporting Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 While Presymptomatic or Asymptomatic.","Recent epidemiologic, virologic, and modeling reports support the possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from persons who are presymptomatic (SARS-CoV-2 detected before symptom onset) or asymptomatic (SARS-CoV-2 detected but symptoms never develop). SARS-CoV-2 transmission in the absence of symptoms reinforces the value of measures that prevent the spread of SARS-CoV-2 by infected persons who may not exhibit illness despite being infectious. Critical knowledge gaps include the relative incidence of asymptomatic and symptomatic SARS-CoV-2 infection, the public health interventions that prevent asymptomatic transmission, and the question of whether asymptomatic SARS-CoV-2 infection confers protective immunity.","Emerg Infect Dis","Furukawa, Nathan W","Brooks, John T","Sobel, Jeremy","32364890"],"abstract":["Recent epidemiologic, virologic, and modeling reports support the possibility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission from persons who are presymptomatic (SARS-CoV-2 detected before symptom onset) or asymptomatic (SARS-CoV-2 detected but symptoms never develop). SARS-CoV-2 transmission in the absence of symptoms reinforces the value of measures that prevent the spread of SARS-CoV-2 by infected persons who may not exhibit illness despite being infectious. Critical knowledge gaps include the relative incidence of asymptomatic and symptomatic SARS-CoV-2 infection, the public health interventions that prevent asymptomatic transmission, and the question of whether asymptomatic SARS-CoV-2 infection confers protective immunity."],"journal":"Emerg Infect Dis","authors":["Furukawa, Nathan W","Brooks, John T","Sobel, Jeremy"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32364890","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.3201/eid2607.201595","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","asymptomatic","coronavirus disease","presymptomatic","respiratory infections","review","severe acute respiratory syndrome coronavirus 2","transmission","viruses","zoonoses"],"topics":["Transmission"],"weight":1,"_version_":1666138495989579777,"score":133.8489},{"pmid":32470316,"title":"Investigation and Serologic Follow-Up of Contacts of Early Confirmed Case-Patient with COVID-19, United States.","text":["Investigation and Serologic Follow-Up of Contacts of Early Confirmed Case-Patient with COVID-19, United States.","We describe the contact investigation for an early confirmed case of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in the United States. Contacts of the case-patient were identified, actively monitored for symptoms, interviewed for a detailed exposure history, and tested for SARS-CoV-2 infection by real-time reverse transcription PCR (rRT-PCR) and ELISA. Fifty contacts were identified and 38 (76%) were interviewed, of whom 11 (29%) reported unprotected face-to-face interaction with the case-patient. Thirty-seven (74%) had respiratory specimens tested by rRT-PCR, and all tested negative. Twenty-three (46%) had ELISA performed on serum samples collected approximately 6 weeks after exposure, and none had detectable antibodies to SARS-CoV-2. Among contacts who were tested, no secondary transmission was identified in this investigation, despite unprotected close interactions with the infectious case-patient.","Emerg Infect Dis","Chu, Victoria T","Freeman-Ponder, Brandi","Lindquist, Scott","Spitters, Christopher","Kawakami, Vance","Dyal, Jonathan W","Clark, Shauna","Bruce, Hollianne","Duchin, Jeffrey S","DeBolt, Chas","Podczervinski, Sara","D'Angeli, Marisa","Pettrone, Kristen","Zacks, Rachael","Vahey, Grace","Holshue, Michelle L","Lang, Misty","Burke, Rachel M","Rolfes, Melissa A","Marlow, Mariel","Midgley, Claire M","Lu, Xiaoyan","Lindstrom, Stephen","Hall, Aron J","Fry, Alicia M","Thornburg, Natalie J","Gerber, Susan I","Pillai, Satish K","Biggs, Holly M","32470316"],"abstract":["We describe the contact investigation for an early confirmed case of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in the United States. Contacts of the case-patient were identified, actively monitored for symptoms, interviewed for a detailed exposure history, and tested for SARS-CoV-2 infection by real-time reverse transcription PCR (rRT-PCR) and ELISA. Fifty contacts were identified and 38 (76%) were interviewed, of whom 11 (29%) reported unprotected face-to-face interaction with the case-patient. Thirty-seven (74%) had respiratory specimens tested by rRT-PCR, and all tested negative. Twenty-three (46%) had ELISA performed on serum samples collected approximately 6 weeks after exposure, and none had detectable antibodies to SARS-CoV-2. Among contacts who were tested, no secondary transmission was identified in this investigation, despite unprotected close interactions with the infectious case-patient."],"journal":"Emerg Infect Dis","authors":["Chu, Victoria T","Freeman-Ponder, Brandi","Lindquist, Scott","Spitters, Christopher","Kawakami, Vance","Dyal, Jonathan W","Clark, Shauna","Bruce, Hollianne","Duchin, Jeffrey S","DeBolt, Chas","Podczervinski, Sara","D'Angeli, Marisa","Pettrone, Kristen","Zacks, Rachael","Vahey, Grace","Holshue, Michelle L","Lang, Misty","Burke, Rachel M","Rolfes, Melissa A","Marlow, Mariel","Midgley, Claire M","Lu, Xiaoyan","Lindstrom, Stephen","Hall, Aron J","Fry, Alicia M","Thornburg, Natalie J","Gerber, Susan I","Pillai, Satish K","Biggs, Holly M"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470316","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.3201/eid2608.201423","keywords":["2019 novel coronavirus disease","covid-19","sars-cov-2","contact tracing","coronavirus","coronavirus disease","respiratory infections","serology","severe acute respiratory syndrome coronavirus 2","viruses","zoonoses"],"locations":["United States","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention","Diagnosis"],"weight":1,"_version_":1668420887284547585,"score":133.52806}]}